.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Serving leading biopharmaceutical companies globally:

UBS
Baxter
Mallinckrodt
Harvard Business School
McKinsey
Fuji
Cantor Fitzgerald
Chinese Patent Office
Cipla
Express Scripts

Most drug patent challenges last year

This chart shows the generic firms that had the most successful drug patent challenges last year.

Companies that successfully challenge patents on branded drugs are granted six months of generic exclusivity. And, because first-to-market generics tend to sell at 70% or more of the price of the branded drug, the financial rewards stemming from the market exclusivity granted for drug patent challenges can more than cover the subtantial costs of drug patent challenge and associated litigation.

The most successful patent challengers in 2016 were

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot